CURRENT ISSUE

Genetic Engineering " Biotechnology News - Current Issue

(view larger image)

SUBSCRIBE

AD LINK

Visit GEN on Twitter!

Breaking News

  • Print
  • Share
  • More News

Apr 27 2006, 11:34 AM EST

The CryoPen Cryosurgical System was designed to replace outdated cryosurgical instruments by using the newest cooling technology to eliminate the need for cryogenic gases or liquids. (Photo: Business Wire)

News source: Business Wire

The most advanced, state-of-the-art technology in the field of cryosurgery, the CryoPen(R) Cryosurgical System, was recently launched by CryoPen, LLC, announced Dr. Michael Haas, the technology's inventor.

"The CryoPen is the most significant cryosurgical advance in a generation and will most certainly revolutionize cryosurgery. The last new technology in the field was more than 30 years ago," said Haas, CryoPen President.

The CryoPen is the safest instrument available because it uses a state-of-the-art, linear compression cooling technology that does not require handling of dangerous cryogenic gases and liquids, such as with existing cryosurgical technologies of the 1970s. In addition to not being exposed to potentially dangerous gases or liquids, the pen-point precision and consistent freeze temperature of the CryoPen reduces the risks of serious burns, according to Haas.

"The non-evasive, patient-friendly CryoPen is also the most effective cryosurgical technique because it simplifies the complexities involved by predetermining variables, such as time, angle, and distance," Haas added. "Once the system is at optimal temperature, the CryoPen is ready for accurate and predictable cryosurgery."

The CryoPen also makes cryosurgery safer and easier for office staff, who will no longer have to regularly handle and order hazardous gases or liquids mandatory of most traditional methods. Plus, with the CryoPen, the treatment has a minimal scarring and no need for anesthetic.

The CryoPen, which has established American Medical Association CPT(TM) codes and can be treated without referral, is used in the treatment of:

-- warts/plantar warts

-- lentigo

-- dermatafibroma

-- seborrheic keratoses

-- non-recurrent basal cell

-- molluscum

-- actinic keratoses

-- keloids

-- skin tags

For some procedures, reimbursement is more than $200, according to national averages derived from the Centers for Medicare and Medicaid Services data.

Dr. Kyle Dean, a Louisiana physician who has used the CryoPen in his practice, said he considered the CryoPen one of the best equipment purchases that he has ever made.

"My staff no longer uses valuable time pouring liquid nitrogen from one container to another," Dean said. "And, if there is a delay in the treating a patient, I do not have to worry; the pens stay ready for 30 minutes, whereas liquid nitrogen would have evaporated."

CryoPen, LLC is a leading cryosurgical innovator, designing, developing, marketing and selling its CryoPen Surgical System to primary care physicians, family practice physicians, general practice physicians, obstetrics and gynecologists, pediatricians, internists and dermatologists. To find out more about the CryoPen, visit www.cryopen.com or call us at 888-246-3928.

  • Print
  • Share
  • More News

CAREER CENTER

Visit the GEN Career Center

for the latest biotech employment opportunities.
Start your search HERE!

visit the Career Center

WEBINARS


view all webinars

GEN and Scintellix bring you the Cryptogram Challenge: RNAi!

PODCASTS

INTERVIEW: NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates ...MORE

MOST POPULAR

News

Articles

Blogs